key: cord-0804968-nj7cmbsd
authors: Shah, S.; Chitre, D.
title: P.123 Patient follow-up after obstetric anaesthetic intervention during the COVID-19 pandemic lockdowns
date: 2022-05-31
journal: International Journal of Obstetric Anesthesia
DOI: 10.1016/j.ijoa.2022.103419
sha: 082812f08bebca1cec49eebde1c8297aef6f9bab
doc_id: 804968
cord_uid: nj7cmbsd

nan

We conducted an OAA approved survey, sent electronically to 141 lead obstetric anaesthetists. Questions examined current PNA practices, existing or planned SAM regimens and perceived benefits and barriers to SAM regimens. Results: Forty-five responses were received (32% response rate). 98% reported the anaesthetist has the responsibility of prescribing PNA. 13% reported use of a SAM regime for PNA which includes paracetamol, an oral anti-inflammatory, and in one unit, oramorph. A further 20% reported plans to introduce a SAM regimen, 58% had no plans, and the remainder were unsure whether any plans were in place. Perceived benefits of SAM regimens included reduced workload (87%), reduced delays and increased patient satisfaction (84%) and improved pain scores (62%). Barriers reported comprised concerns over record keeping (78%), safe medicine storage (64%), challenges in non-English speaking patients (42%), dosing errors (42%), lack of pharmacy buy-in (38%), staff reluctance and staff shortages (both 31%). Discussion: The survey responses suggest support for the concept of SAM regimens. There were some notable challenges to implementation: transitioning to e-prescribing resulting in the collapse of one hospital's initial success; variation in prescribing practices between individuals, resistance from other professional groups, and concerns around patient education. Those units reporting successful SAM regimen implementation highlighted the importance of collaborative working between staff groups. Multiple respondents would welcome a national policy on SAM for PNA to empower individual units to improve services. As the role of the anaesthetist as the perioperative physician expands, we can be expected to have a leading role in PNA. SAM requires a multi-disciplinary integrated approach and mutual support between departments to be implemented effectively and ultimately improve patient experience. P.122 Improving follow up after obstetric anaesthetic intervention M. Bigwood, A. Ling

Introduction: Both the RCoA and Obstetric Anaesthetists' Association state that all women who have had regional analgesia, anaesthesia or a GA should be reviewed afterwards [1, 2] . This is to screen for complications and to collect feedback. In our trust the percentage of our women reviewed was low. The reasons for this is multifactorial. The main two are that few complications are picked up (as most are picked up by the midwives) and there is not much educational value in carrying out these reviews. Methods: Follow-up lists are generated from an electronic maternity record and women are seen in turn using a recommended national question set. Data recorded in handheld written notes are then transcribed to the electronic maternity record. Our proposed change was to introduce a patient self-completed review questionnaire. It was devised based on the paper documentation already in use. We agreed with anaesthetists and midwives that we initially trial the new process for women who had elective caesarean section. The forms would be given out the morning after their operation. They are then collected and transcribed onto the electronic record. We included on the form a 'safety netting' question that would automatically trigger an in person review. Data were collected for 8 weeks prior to the intervention (baseline) and for 4 weeks afterwards. Results: After introducing our follow up questionnaire there was an increase in the percentage of women followed up overall (30% to 49%) with a more substantial increase found in the targeted elective caesarean group (25% to 55%) compared to non-elective interventions (32% to 47%). Discussion: It is notable that follow-up rates improved generally in the target period and this could be related to a generalised increase in engagement with the process whilst it was under scrutiny. Our registrars (who are tasked with carrying out the reviews) found that the process reduced the time needed to complete the task. Feedback from both midwives and anaesthetists was positive. It was recognised that the form (currently) is only available in English and would benefit from being available in other languages. Also, if the ward midwives are under time pressure it does add to their work burden. Our wider aims are to develop the process so that it is inclusive of more languages, electronic data entry is directly to the maternity system and flags for urgent clinical reviews are directed to the anaesthetists. 

Introduction: The COVID-19 pandemic led to a series of national lockdowns in England. We reviewed the obstetric anaesthetic follow up rate and patient satisfaction during the national lockdowns in 2020. Methods: This study, conducted at Southend University Hospital maternity unit, compares two cohorts. Cohort A from 23 March to 10 May 2020, and Cohort B from 5 November to 1 December 2020, which align with the first and second national lockdowns, respectively. All obstetric episodes with anaesthetic input during these periods were obtained from electronic patient records (CSC software) and analysed using Microsoft Excel. Discussion: Best practice guidelines advise follow up of all patients receiving obstetric anaesthetic intervention [1] . This study demonstrates low follow-up rates, especially during the first lockdown. Early discharge following delivery may have made follow up logistically challenging. In the early stages of the pandemic, minimising unnecessary face-to-face contact, due to the unknowns of COVID-19, was most likely a contributing factor for low follow up rates. Patient satisfaction is also likely to have been impacted due to altered clinical practice over the lockdowns. Missing follow-up data must be acknowledged as potential complications may have been missed. 

Introduction: In 2021, PROSPECT updated guidelines related to analgesia for caesarean Section (CS) including regular paracetamol and NSAID in addition to a single dose of IV dexamethasone after delivery [1] . Previous local audits between 2009 and 2015 had revealed a large percentage of omitted analgesic drug doses postoperatively and incorrect prescribing of postoperative ibuprofen after intra-operative diclofenac. This led to implementation of enhanced recovery pre-printed drug charts and the addition of prescribing safety reminders at the WHO sign out. We re-audited looking for improvement of these issues and compliance with new PROSPECT guidelines. Methods: A retrospective audit was performed via note review of parturients undergoing CS in April and July 2021. Approval was granted by the local clinical governance department. Results: 89 notes were reviewed and included (April n = 43, July n = 46 

Introduction: Caesarean section (CS) can be associated with moderate to severe pain which may delay recovery, impair bonding and breastfeeding and negatively impact upon maternal psychological wellbeing [1] . In 2021, PROSPECT updated guidelines relating to CS which include intrathecal or epidural diamorphine or morphine aiming to reduce systemic opioid use [1] . Ongoing diamorphine supply issues in the UK completely precluded its use on our labour ward in July 2021 and, due to recent adverse events associated with intrathecal morphine in other patient groups, the only opioid on formulary was fentanyl.

Methods: A retrospective service evaluation was completed via note review of parturients undergoing CS in April and July 2021. Approval was granted by the local clinical governance department.

Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression

Raising the Standards: RCOA quality improvement compendium

Guidelines for the Provision of Anaesthesia Services in an Obstetric Population

PROSPECT guideline for elective caesarean section: updated systematic review and procedure-specific post-operative pain management recommendations

Obstetric Anaesthetists' Association. OAA commentary on alternatives to intrathecal and epidural diamorphine for caesarean section analgesia